Jia Wei
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Immunology top 2%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Oncology 62
- Cancer Immunotherapy and Biomarkers 22
- CAR-T cell therapy research 16
- Co-authors
- Baorui Liu (88 shared papers)Lixia Yu (47 shared papers)Tao Shi (17 shared papers)Xiaoping Qian (22 shared papers)Zhengyun Zou (30 shared papers)Xueru Song (11 shared papers)Fanyan Meng (14 shared papers)Fangcen Liu (7 shared papers)
- Journals
- Journal of Clinical Oncology (18 papers)Frontiers in Oncology (6 papers)Annals of Oncology (6 papers)Cancer Letters (5 papers)Advanced Science (4 papers)
- Partner nations
- ChinaUnited StatesSpain
In The Last Decade
Jia Wei
154 papers receiving 4.0k citations
Peers
Comparison fields: 5 of 120
- Oncology 1.4k
- Immunology 883
- Cancer Research 454
- Biomaterials 305
- Molecular Biology 1.3k
Countries citing papers authored by Jia Wei
This map shows the geographic impact of Jia Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jia Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jia Wei more than expected).
Fields of papers citing papers by Jia Wei
This network shows the impact of papers produced by Jia Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jia Wei. The network helps show where Jia Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Jia Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 163 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 290 | |
| 2 | 2019 | 176 | |
| 3 | 2020 | 160 | |
| 4 | 2020 | 136 | |
| 5 | 2021 | 125 | |
| 6 | 2017 | 120 | |
| 7 | 2021 | 116 | |
| 8 | 2013 | 106 | |
| 9 | 2008 | 98 | |
| 10 | 2008 | 85 | |
| 11 | 2016 | 83 | |
| 12 | 2022 | 79 | |
| 13 | 2021 | 79 | |
| 14 | 2020 | 78 | |
| 15 | 2021 | 74 | |
| 16 | 2022 | 73 | |
| 17 | 2023 | 67 | |
| 18 | 2021 | 60 | |
| 19 | 2008 | 58 | |
| 20 | 2016 | 56 |
About Jia Wei
Jia Wei is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Immunology and Biomedical Engineering, having authored 163 papers that have together received 4.0k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (22 papers), Cancer Immunotherapy and Biomarkers (22 papers), Immunotherapy and Immune Responses (21 papers), CAR-T cell therapy research (16 papers), Nanoplatforms for cancer theranostics (13 papers), Immune Cell Function and Interaction (12 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers). The work is most often cited by research in Oncology (1.4k citations), Immunology (883 citations), Cancer Research (454 citations), Biomaterials (305 citations) and Molecular Biology (1.3k citations). Jia Wei has collaborated with scholars based in China, United States and Spain. Frequent co-authors include Baorui Liu, Lixia Yu, Tao Shi, Xiaoping Qian, Zhengyun Zou, Xueru Song, Fanyan Meng, Fangcen Liu, Xiaoping Qian and Hanbing Wang. Their work appears in journals such as Journal of Clinical Oncology, Frontiers in Oncology, Annals of Oncology, Cancer Letters and Advanced Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.